![icad inc. icad inc.](https://charts.equityclock.com/seasonal_charts/ICAD_sheet.png)
The Company sells its products through its direct sales organization, as well as through various original equipment manufacturer partners, distributors and resellers.
![icad inc. icad inc.](https://s1.manualzz.com/store/data/006349499_1-4414f26cb10b29101384a8dae35d3896-360x466.png)
The Therapy segment consists of its radiation therapy products and offers the Xoft System, which is an isotope-free cancer treatment platform technology. It operates through two segments, Cancer Detection and Cancer Therapy. The Detection segment consists of its image analysis and workflow products, a range of Artificial Intelligence (AI), Computer-Aided Detection (CAD) systems and workflow solutions for two-dimensional (2D) and three-dimensional (3D) mammography, Magnetic Resonance Imaging (MRI) and Computed Tomography (CT). provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. iCAD delivers innovative cancer detection solutions that enable clinicians to find cancers earlier and faster while enhancing patient. For financial reporting, their fiscal year ends on December 31st. Icad Inc is primarely in the business of surgical & medical instruments & apparatus. The Company operates through two segments: Cancer Detection (Detection) and Cancer Therapy (Therapy). Security and Exchange Commission and incorporated in the state of Delaware. is a global medical technology company providing cancer detection and therapy solutions.